Every parliamentary written question tabled by Mark Francois this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 21–39 of 39 · Department of Health and Social Care
When NHS East of England plans to publish an annual report for 2024-25.
National Health Service East of England is a regional team within NHS England, and as such they do not publish an annual report. The NHS England’s annual report and accounts includes the regional teams, other NHS England operations, and group bodies.
What estimate he has made of the operating deficit for the Mid and South Essex Hospitals NHS Trust for financial years (a) 2023-24, (b) 2024-25 and (c) 2025-26.
Trusts report their deficit position in their board reports, which are published on their websites. In 2023/24, the Mid and South Essex Foundation Trust reported an operating deficit of £29.7 million, resulting in the organisation being placed into the National Recovery Support Programme to receive support for improving its financial position. The 2024/25 financial plan for the foundation trust was a deficit of £84.6 million, for which the organisation has received deficit support funding from NHS England. Following receipt of this funding, the foundation trust is forecast to breakeven, although this requires the trust to deliver improved positions in the final months of the year, as there is a year-to-date deficit at month seven of £23.1 million, according to their latest board report. NHS England recently published 2025/6 Planning Guidance to support system financial planning for 2025/26. Finalised system financial plans for 2025/26 are currently being developed ahead of the start of the financial year, and so are not yet available.
What the salary band is of the Regional Director of Strategy and Integration for the NHS East of England.
The salary bands for the Regional Director, Finance Director, Strategy Director, and Chief Operating Officer for NHS East of England are as follows:Executive Senior Manager (ESM) Grade 3 for the Regional Director;ESM Grade 2 for the Finance Director;ESM Grade 2 for the Strategy Director; andESM Grade 2 for the Chief Operating Officer.These bandings are the same across all of NHS England for these roles.
How many full-time equivalent staff are employed by the NHS East of England headquarters.
The NHS England East of England regional whole time equivalent for this establishment is 637. This is the number of posts, rather than the number of staff currently employed. The data for the total number of full-time equivalent staff employed is unvalidated and is subject to change, so it is not routinely published.
What the salary band is for the Regional Director of the NHS East of England.
The salary bands for the Regional Director, Finance Director, Strategy Director, and Chief Operating Officer for NHS East of England are as follows:Executive Senior Manager (ESM) Grade 3 for the Regional Director;ESM Grade 2 for the Finance Director;ESM Grade 2 for the Strategy Director; andESM Grade 2 for the Chief Operating Officer.These bandings are the same across all of NHS England for these roles.
What the salary band is for the Finance Director of the NHS East of England.
The salary bands for the Regional Director, Finance Director, Strategy Director, and Chief Operating Officer for NHS East of England are as follows:Executive Senior Manager (ESM) Grade 3 for the Regional Director;ESM Grade 2 for the Finance Director;ESM Grade 2 for the Strategy Director; andESM Grade 2 for the Chief Operating Officer.These bandings are the same across all of NHS England for these roles.
What information his Department holds on when the Mid and South Essex NHS Foundation Trust plans to publish it's 2024-25 Annual Report.
The Annual Report and Accounts of the Mid and South Essex NHS Foundation Trust for 2024/2025 will be published ahead of the trust’s Annual General Meeting, which is usually held at the end of September. Publication can only take place after the Annual Report and Accounts have been laid before Parliament, in line with NHS England guidance.
What the salary band is of the Chief Operating Officer of the NHS East of England.
The salary bands for the Regional Director, Finance Director, Strategy Director, and Chief Operating Officer for NHS East of England are as follows:Executive Senior Manager (ESM) Grade 3 for the Regional Director;ESM Grade 2 for the Finance Director;ESM Grade 2 for the Strategy Director; andESM Grade 2 for the Chief Operating Officer.These bandings are the same across all of NHS England for these roles.
What the salary bands are for the (a) Chief Executive, (b) Chief Operating Officer, (c) Finance Director and (d) Medical Director at Mid & South Essex Hospitals NHS Trust.
Information on the renumeration of senior staff is published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust is available at the following link:https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
How many (a) communications and (b) media staff are employed by Mid & South Essex Hospitals NHS Trust.
The Department does not hold the information requested.
What the salary bands are for the Managing Director of (a) Southend Hospital, (b) Basildon Hospital and (c) Broomfield hospital; and when the people in these roles were appointed.
The Department does not hold the information requested. Information on the renumeration and biographies of senior staff are published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust, including biographies of senior staff, is available at the following link:https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
How many equality, diversity and inclusion managers are employed by the Mid and South Essex Hospitals NHS Trust.
The Department does not hold the information requested.
What role Price Waterhouse Coopers have been assigned in assisting with the financial management of the Mid & South Essex NHS Hospitals Trust; how long this task has been assigned for; what the cost to the public purse is; and what outputs they are required to deliver.
PricewaterhouseCoopers (PwC) received a direct award to undertake a nationally mandated Investigation and Intervention programme at the Mid and South Essex Integrated Care Board, to support it in delivering its financial plan.The programme lasted eight weeks, and the cost of phase one was £246,187, which the Mid and South Essex NHS Foundation Trust and the integrated care board incurred. The output was a report recommending actions the system should take to recover its in-year plan.The Mid and South Essex Integrated Care Board decided to secure additional support from PwC for phase two from mid-July to the end of October 2024, which cost £1.07 million. This evolved into a programme of work supporting direct intervention within and across the foundation trust’s hospital sites.
What proportion of leukaemia patients were offered a holistic needs assessment in the last 12 months.
NHS England has committed to ensuring that all cancer patients have access to a Holistic Needs Assessment, ensuring care is focused on what matters most to each person.The 2023 England National Cancer Patient Experience Survey indicates the proportion of people with Leukaemia who reported having had a discussion with a member of the team looking after them, before their treatment started, about their needs or concerns was 72.6%. For people with Leukaemia, a further 24.5% said they had the discussion to some extent, and a total of 97.1% reported having had a discussion.
What plans he has to develop a best practice pathway for (a) leukaemia and (b) other blood cancers.
NHS England has implemented non-symptom specific pathways for patients who present with symptoms that can indicate several different cancers, including leukaemia. An NHS England national evaluation showed blood cancers are one of the most common cancer types diagnosed through these pathways.
What assessment he has made of the adequacy of five-year survival rates for (a) acute myeloid leukaemia and (b) other leukaemias.
The age-standardised, one-year net survival for adults, those aged 15 to 99 years old, diagnosed with leukaemia between 2016 and 2020 in England was 74.4%, and the five-year survival rate was 55.9%.NHS England has implemented non symptom specific pathways for patients who present with non-specific symptoms or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. The national evaluation showed that blood cancers are one of the most common cancer types diagnosed through these pathways.Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.Cancer patients are being failed, waiting too long for a diagnosis and treatment. We will bring down waits for cancer appointments with the Fit For the Future fund, doubling the number of state-of-the-art magnetic resonance imaging and computed tomography in the National Health Service to ensure early diagnosis and faster treatment.
What plans he has to implement a cancer strategy over the course of this Parliament.
Professor Lord Darzi is currently undertaking an independent investigation into the state of the National Health Service, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Governme...
Whether the evaluation of non-specific pathways will include granular blood cancer data.
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.NHS England has implemented non-symptom...
What steps his Department is taking to ensure consistent publication of data on waiting times for (a) leukaemia and (b) other cancer treatments.
Cancer waiting time data is collected by NHS England according to three performance standards: the Faster Diagnosis Standard (FDS), which aims to ensure patients have cancer diagnosed or ruled out within 28 days of referral from a general practice or screening service; the 31-day wait from a decision to treat to first or subsequent treatment of cancer combined standard; and the 62-day referral to first definitive treatment for cancer combined standard. Data can then be broken down by cancer type. For the FDS, data regarding leukaemia and its sub-types is collected using the following two categories, suspected acute leukaemia and suspected haematological malignancies, excluding acute leukaemia. The latter category includes non-acute leukaemia when there is a suspicion. These statistics are published monthly and are available at the following link: https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/